WASHINGTON | The Pentagon announced Tuesday, have awarded a contract of $ 138 million to a company producing pods injectable to allow for a rapid dissemination of a vaccine against the Covid-19 from the fall.
The contract is intended to speed up a project which already participate in the ministry of Health and the us investment bank Jefferies, which is intended to develop the capacity of the company Apiject Systems America, specializing in these miniseringues prédosées and disposable.
This agreement ” will increase dramatically the capacity of production of devices for injectable manufactured locally from October 2020 “, with a production target of 100 million syringes prédosées by the end of the year, the Pentagon said in a press release.
The idea is to be able to ” fight the Covid-19 when a vaccine that is safe and proven to be available “, said the release.
The contract also provides for the creation in Connecticut, South Carolina and Illinois new manufacturing plants “ultrafast” these pods plastic to achieve production of 500 million servings, in 2021.
This agreement ” will help to reduce the reliance of the United States to the production lines of foreign and toward technologies that have aged with time periods of production are more important “, says the Pentagon.
To rebuild an industrial base abandoned over the years in favour of China, the Pentagon is investing for the past two months hundreds of millions of dollars in the purchase of masks, tests, and other pharmaceutical products to u.s. companies.
Several contracts have already been awarded, including a $ 133 million dollars for the production of surgical masks N95 granted to three us companies: 3M, Honeywell, and Owens & Minor.
A company in Maine that specializes in the manufacture of swabs, these great cotton swabs required for the nasal samples used in the tests, have received a contract of $ 75.5 million.